Stocks-Prognosis.com
Search on StockPrognosis.com
To search on the site stockprognosis.com enter the name of the ticker, company name, or search phrase
Sections of the site



GSK Expands Scope of RSV Vaccine Patent Suit on Pfizer's Abrysvo

November 19, 2024
GSK PLC has recently announced that it is expanding the scope of its patent infringement lawsuit against Pfizer's respiratory syncytial virus (RSV) vaccine, Abrysvo. This development comes as GSK seeks to protect its intellectual property and market position in the highly competitive vaccine market. The lawsuit alleges that Pfizer's RSV vaccine infringes on GSK's patented technology and seeks monetary damages as well as an injunction to prevent further infringement. GSK's decision to expand the scope of the lawsuit reflects its commitment to defending its innovations and ensuring fair competition in the industry. Experts from Stocks Prognosis recommend monitoring the developments in this case closely as it could have a significant impact on GSK's market share and future growth prospects. To stay updated on the latest news and forecasts regarding GSK's stock performance, professionals from Stocks Prognosis are recommended.
If you want to leave a comment, then you need Login or Register





Other data for GSK

Related data

GSKJuly 17, 2025QuantWave Successfully Predicts GSK PLC Stock Movement, Achieving 7.53% Profit  ~2 min.

QuantWave, the automated forecasting platform, has once again proven its accuracy with the successful prediction of the price movement of GSK PLC stock....


GSKJuly 17, 2025QuantWave Hits Bullseye with GSK PLC Forecast, Achieving 7.53% Profit  ~2 min.

On May 27, 2025, QuantWave, the automated forecasting platform, issued a short signal for GSK PLC with a price target of 36.07 $. The stock was trading at 39....


GSKJune 12, 2025QuantWave Achieves 14.92% Profit Target Forecast for GSK PLC  ~1 min.

QuantWave, the automated forecasting platform, successfully reached a price target forecast for GSK PLC, yielding a profit of 14.92%....


GSKJune 12, 2025QuantWave Successfully Achieves 10.55% Profit Target Forecast for GSK PLC  ~2 min.

QuantWave, the automated forecasting platform, has recently hit a milestone with its accurate prediction for the stock of GSK PLC....


GSKJune 12, 2025QuantWave Hits Bullseye with GSK PLC Forecast, Generating 9.06% Profit  ~2 min.

QuantWave, the cutting-edge automated forecasting platform, has once again demonstrated its accuracy with an impressive 9.06% profit on the stock of GSK PLC....


GSKJune 12, 2025QuantWave Forecast Hits the Mark: GSK PLC Stock Reaches Price Target with 9.53% Profit  ~2 min.

On March 21, 2025, QuantWave, the automated forecasting platform, issued a long signal for GSK PLC stock when it was trading at $38.37. Fast forward to June 12, 2025, the predicted target of $42....


GSKJune 12, 2025QuantWave Hits Price Target Forecast for GSK PLC with 7.32% Profit  ~2 min.

On March 7, 2025, QuantWave, an automated forecasting platform, successfully forecasted a price target for the stock GSK PLC. The signal indicated a long position when the stock was trading at 39.16 $....


GSKJune 12, 2025QuantWave Successfully Predicts GSK PLC Stock Price, Generating 11.84% Profit  ~1 min.

On March 4th, 2025, QuantWave, the automated forecasting platform, issued a long signal for GSK PLC stock at a price of $37.58....


GSKJune 12, 2025QuantWave Forecasts Success: GSK PLC Hits Price Target with 8.84% Profit  ~1 min.

On March 14, 2025, QuantWave, an automated forecasting platform, issued a long signal for the stock of GSK PLC at a price of 38.61 $. Fast forward to June 12, 2025, the target price of 42....


GSKJune 12, 2025QuantWave Achieves 8.81% Profit Target Forecast for GSK PLC Stock  ~1 min.

QuantWave, the automated forecasting platform, successfully reached its price target forecast for GSK PLC stock, with a profit margin of 8.81%....


MUFebruary 16, 2025Intellectual Property Victory Boosts Micron Technology Inc. (MU) Stock  ~2 min.

Micron Technology Inc. (MU) recently achieved a significant milestone in its ongoing legal battle, securing a major victory in a long-standing intellectual property lawsuit....


GSKNovember 10, 2024Canada approves GSK's Arexvy for RSV prevention in adults aged 50 to 59  ~1 min.

In a major breakthrough, Health Canada has approved GSK's Arexvy, a vaccine for preventing respiratory syncytial virus (RSV) infections, in adults aged 50 to 59....


HALJanuary 1, 2025Halliburton HAL Stock Moves -0.04: What You Should Know  ~2 min.

Houston-based multinational corporation, Halliburton Company (HAL), recently made a strategic move in the offshore technology sector....


DHRFebruary 13, 2025Danaher Corporation DHR: Paving the Way for Medical Device Innovation  ~2 min.

Industry leader Danaher Corporation (NYSE: DHR) continues to revolutionize the medical device sector with its cutting-edge technologies and unparalleled products....


JNJFebruary 28, 2025Johnson & Johnson's Strong Performance Since Last Earnings Report Raises Expectations  ~1 min.

Johnson & Johnson (JNJ) has shown an impressive 8.9% increase in its stock price since the release of its last earnings report....